Clinical studies have shown thatweight loss can improve fatty liver, and that reduced liver fat content conferslower serum fasting insulin and triglyceride (TG) concentrations relative tosubjects with high levels of liver fat (4).Weight reduction and adequate control of diabetes (main complication) is thestandard treatment for NAFLD. The gene discussed is INS; the disease is Hepatic steatosis.